More Than Two-Thirds of Post-Op Patients Have Unused Opioids

Share this content:
More Than Two-Thirds of Post-Op Patients Have Unused Opioids
More Than Two-Thirds of Post-Op Patients Have Unused Opioids

FRIDAY, Aug. 4, 2017 (HealthDay News) -- Postoperative prescription opioids are often unused and improperly disposed of, according to a review published online Aug. 2 in JAMA Surgery.

Mark C. Bicket, M.D., from Johns Hopkins University in Baltimore, and colleagues conducted a systematic review to quantify how commonly postoperative prescription opioids are unused, why they remain unused, and what practices are followed regarding their storage and disposal. Oversupply was defined as the number of patients with either filled but unused opioid prescriptions or unfilled opioid prescriptions.

Based on six studies (with 810 unique patients undergoing seven different types of surgical procedures), the researchers found that between 67 and 92 percent of patients reported unused opioids (42 to 71 percent of all the opioid tablets). Opioids were stopped or not used because of adequate pain control (71 to 83 percent of patients) or opioid-induced adverse effects (16 to 29 percent of patients). Low rates of anticipated or actual disposal were reported in all studies. Further, no study reported that more than 9 percent of patients used U.S. Food and Drug Administration-recommended disposal methods.

"Postoperative prescription opioids often go unused, unlocked, and undisposed, suggesting an important reservoir of opioids contributing to nonmedical use of these products, which could cause injuries or even deaths," the authors write.

One author disclosed financial ties to the pain management industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Salmonella Outbreak in 26 States Linked to Raw Turkey Products

<i>Salmonella</i> Outbreak in 26 States Linked to Raw ...

40 individuals have been hospitalized to date; no deaths have been reported

FDA Recalls Drugs Containing Active Ingredient Valsartan

FDA Recalls Drugs Containing Active Ingredient Valsartan

All lots of non-expired products that contain valsartan supplied by Zhejiang Huahai being recalled

Atopic Dermatitis Places Heavy Burden on Patients

Atopic Dermatitis Places Heavy Burden on Patients

Overall and mental health, life satisfaction all impacted, especially for moderate, severe disease

is free, fast, and customized just for you!




Already a member?

Sign In Now »